These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 3143638)

  • 1. A phase I study of intravenous bryostatin 1 in patients with advanced cancer.
    Prendiville J; Crowther D; Thatcher N; Woll PJ; Fox BW; McGown A; Testa N; Stern P; McDermott R; Potter M
    Br J Cancer; 1993 Aug; 68(2):418-24. PubMed ID: 8347500
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antineoplastic bryostatins are multipotential stimulators of human hematopoietic progenitor cells.
    May WS; Sharkis SJ; Esa AH; Gebbia V; Kraft AS; Pettit GR; Sensenbrenner LL
    Proc Natl Acad Sci U S A; 1987 Dec; 84(23):8483-7. PubMed ID: 3317410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The action of bryostatin on normal human hematopoietic progenitors is mediated by accessory cell release of growth factors.
    Sharkis SJ; Jones RJ; Bellis ML; Demetri GD; Griffin JD; Civin C; May WS
    Blood; 1990 Aug; 76(4):716-20. PubMed ID: 2200537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of the activity of a human granulocyte-macrophage colony-stimulating factor/interleukin-3 fusion protein (pIXY 321) by the macrocyclic lactone protein kinase C activator bryostatin 1.
    McCrady CW; Li F; Pettit GR; Grant S
    Exp Hematol; 1993 Jul; 21(7):893-900. PubMed ID: 7686503
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of bryostatin-1 on chronic myeloid leukaemia-derived haematopoietic progenitors.
    Thijsen SF; Schuurhuis GJ; van Oostveen JW; Theijsmeijer AP; van der Hem KG; Odding JH; Dräger AM; Ossenkoppele GJ
    Br J Cancer; 1999 Mar; 79(9-10):1406-12. PubMed ID: 10188883
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of growth factors in the activity of pharmacological differentiation agents.
    Matsui WH; Gladstone DE; Vala MS; Barber JP; Brodsky RA; Smith BD; Jones RJ
    Cell Growth Differ; 2002 Jun; 13(6):275-83. PubMed ID: 12114217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in vitro effect of the antineoplastic agent bryostatin 4 on human hematopoietic progenitor cells.
    Gebbia V; Di Marco P; Miceli S; Reyes MB; Teresi M; Bonaccorso R; Citarrella P; Rausa L
    Haematologica; 1988; 73(5):387-91. PubMed ID: 3143638
    [No Abstract]   [Full Text] [Related]  

  • 8. Bryostatin 1: differentiating agent from the depths.
    Stone RM
    Leuk Res; 1997 May; 21(5):399-401. PubMed ID: 9225066
    [No Abstract]   [Full Text] [Related]  

  • 9. The use of hematopoietic growth factors for high-dose chemotherapy and peripheral blood progenitor cell transplantation.
    Kanz L; Brugger W; Mertelsmann R
    Semin Oncol; 1994 Dec; 21(6 Suppl 16):10-8. PubMed ID: 7528446
    [No Abstract]   [Full Text] [Related]  

  • 10. The clinical development of the bryostatins.
    Clamp A; Jayson GC
    Anticancer Drugs; 2002 Aug; 13(7):673-83. PubMed ID: 12187323
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical screening of in vivo interactions between myelopoietic growth factors and antitumour drugs for therapy of myeloid leukaemia patients (review).
    Hassan HT; Maurer HR
    In Vivo; 1991; 5(4):307-11. PubMed ID: 1810414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological effects and clinical applications of human colony stimulating factors.
    Gabrilove JL
    Cancer Chemother Biol Response Modif; 1988; 10():492-506. PubMed ID: 3079396
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.